Outcomes Report 2024
A reflection of the expertise of Michigan’s most comprehensive transplant program, this 2024 Outcomes Report offers the data that supports the expertise of a nationally recognized team of surgical and medical experts. Henry Ford has proven yet another year to be Michigan’s Transplant Program and shaping the future of transplantation.
Michigan’s Transplant Program
The lives of 316 patients were saved through transplantation and 44 patients became the recipients of a living kidney or liver donation from living donors.
In addition to living donation, use of innovative procedures and use of normothermic machine perfusion has shifted the paradigm in transplantation
Liver Transplant
Coming up on its 37th year anniversary in 2026, liver transplantation at Henry Ford Hospital has numerous achievements. Through visionary leaders and innovation, many milestones have been achieved, including split-liver transplant from a deceased donor and 171 adult-to-adult living donor transplants since the Center for Living Donation was established. From a total of 121 liver transplants, 9 were from living donors in 2024. Normothermic machine perfusion reduces ischemic injury and improves function, which allows for transport from further distances and more healthy livers to transplant. As a result, transplant surgeons predict procedures in 2025 will exceed 2024 liver transplant by 170% due to preservation and transportation using normothermic machine perfusion.
Outcomes
First transplant: 3/30/89 Transplants performed in 2024: 121
Deceased donor: 112
Living donor: 9
Total number of program transplants through 2024: 2,485
Deceased donor: 2,338
Living donor: 147
Received Medicare approval: 1/1/77
work to increase the number of available organs for transplantation.
The successes of the transplantation team are marked by innovations and research that lead to the next great technique or treatment. While we celebrate our successes, it is our patients who are the true beneficiaries.
Kidney Transplant
Robot-assisted and minimally invasive surgery in the Henry Ford Kidney Transplant program is performed by a team of surgeons and transplant nephrologists. Due to irreversible kidney failure these patients who would otherwise be dependent on dialysis experience improved energy and quality of life. A fully range of kidney, pancreas and kidney-pancreas transplants are performed by these experts. As one of the longest-running programs, through 2024 there have been 137 kidney transplants with 35 from living donors.
Outcomes
First transplant: 1/4/68 Transplants performed in 2024: 137
Deceased donor: 96
Living donor: 35
Total number of program transplants through 2022: 4,003
Deceased donor: 2,658
Living donor: 1,345
Transplant rate ~ (expected .278, national .282): .328
Pre-transplant mortality ~ (expected .046, national .052): .033
Pancreas Transplant
Pioneers in Type 1 and Type 2 diabetes management and research, the nationally recognized division of Endocrinology, Diabetes and Metabolism works closely with nephrologists of the Henry Ford Transplant program to help patients in need of a pancreas transplant. Since 1987, there have been 180 pancreas transplants through 2024.
Outcomes
First transplant: 5/11/87
Transplants performed in 2024: 2
Patient Survival Rates for All Pancreas Transplants (PAK, SPK, PTA)*
Total number of program transplants through 2024: 180 Received Medicare approval: 7/1/99
Pre-transplant mortality ~ (expected .040, national .045): .062
Lung Transplant
Experts in single- and double-lung transplantation, the Henry Ford Lung Transplant program includes pulmonologists and cardiothoracic surgeons. Together they provide advanced and end-state lung disease patients an opportunity to extend their lives. Through their expertise, 464 people over the last 30 years have been saved.
While patient’s wait for transplantation, Henry Ford Hospital experts use extracorporeal membrane oxygenation (ECMO) support patient who are in critical condition without use of a ventilator. Allowing the body to rest the lungs, use of ECMO means the patient is in better condition prior to transplant, and post-transplantation as the lungs heal.
Outcomes
First transplant: 10/20/94
Transplants performed in 2024: 27
Total number of program transplants through 2024: 464
Received Medicare approval: 2/1/99
Median time to transplant <: 8.9 months
Waitlist mortality ~ (expected .128, national .121): .133
Survival Rates for Lung Transplant*
Heart Transplant
One of the most advanced multidisciplinary Advance Heart Failure teams in the country resides within in Henry Ford Heart Transplant. Nationally recognized Henry Ford Transplant program researchers connect their expertise in heart failure to patient care with the latest in therapeutic regiments and mechanical ventricular assist devices. Experts in heart transplant are shaping the future making beating-heart transplantation standard protocol improving the quality of the transplanted heart and patient outcomes.
More than 704 patients with heart failure received a heart transplant and a second chance at life. The team’s expertise in mechanical circulatory support devices extended the life of 44 patients with severe heart failure, an option otherwise not possible at another hospital.
Outcomes
First transplant: 4/23/85
Transplants performed in 2024: 27
Total number of program transplants through 2024: 704
Number of VADs in 2024: 44
Received Medicare approval: 8/2/88
Median time to transplant < (2.4 months nationally, 5.4 months regionally): 1.9 months
Pre-transplant mortality ~ (expected .081, national .081): .081
Outcomes
Intestine/ Multivisceral Transplant
Henry Ford Transplant is the only center in Michigan to provide comprehensive adult intestine and multivisceral transplantation. It remains only one of 10 adult programs in the United States. Those with chronic conditions of the small bowel, and those dependent on total parenteral nutrition, intestine is an option.
The program continues to grow and is highly recognized for additional abdominal organ and pancreas programs that allow for multivisceral transplant. Up to 2024, 51 multivisceral transplants have been performed.
For more information, please contact our outreach coordinators
Michelle “Cookie” Crossley, R.N., B.S.N.
Mobile Phone: (248) 219-2326
Email: MCROSSL1@hfhs.org
Christina Somers, R.N., B.S.N.
Mobile Phone: (313) 622-4352
Email: CSOMERS1@hfhs.org
Katie Dandron, R.N.
Mobile Phone: (313) 353-3990
Email: KDANDRO1@hfhs.org
Transplant Care Available State Wide
The numbers in this report represent many of the transplant patients who may not have had access to transplantation services without the innovative establishment of Henry Ford’s Community Outreach Clinics. Henry Ford brings transplant services to the state of Michigan, services are often located within other hospital facilities and medical buildings, and physicians rotate through these locations or use virtual appointments to ensure care is provided to those who otherwise might not have access.
First transplant: 8/22/10
Transplants performed in 2024: 2
Total number of program transplants through 2024: 51
Received Medicare approval: 2/8/13
Median time to transplant < (11.2 months nationally): 6.2 months
Transplant rate ~ (expected .904, national .545): 1.02
Pre-transplant mortality ~ (expected .068, national .068): 0.0 Patient Survival Rates for Multivisceral Transplant*
Graph data sourced from:
< Patients’ time to transplant between 01/01/2019 and 06/30/2024
~ Patients’ time to transplant between 07/01/2022 and 06/30/2023
# Patients transplanted between 01/01/2024 and 12/31/2024. Devices include ventricular assist devices (VAD), extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), and total artificial heart (TAH)
* Estimated probability of surviving at one year, for patients receiving their first transplant between 01/01/2022 and 06/30/2024; and at three years, for patients receiving their first transplant between 07/01/2019 and 03/12/2020, and 06/13/2020 and 12/31/2021
+ Estimated probability of surviving with a functioning graft at one year, for patients receiving their first transplant between 01/01/2022 and 06/30/2024; and at three years, for patients receiving their first transplant between 07/01/2019 and 03/12/2020, and 06/13/2020 and 12/31/2021
Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available April 30, 2025, released July 8, 2025.
Outreach Clinics are located in:
• Bloomfield Township
• Brownstown
• Clinton Township
• Dearborn
• Detroit
• East Lansing
• Flint
• Grand Blanc
• Grand Rapids
• Grayling
• Jackson
• Muskegon
• Novi
• Pontiac
• Royal Oak
• Saginaw
• Southfield
• Sterling Heights
• Traverse City (coming 2026)
• West Bloomfield
• West Branch
• Wyandotte
• Ypsilanti
